These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9768932

  • 1. Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations.
    Misfeld M, Dubbert S, Eleftheriadis S, Siemens HJ, Wagner T, Sievers HH.
    Ann Thorac Surg; 1998 Sep; 66(3):792-9. PubMed ID: 9768932
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
    Speekenbrink RG, Wildevuur CR, Sturk A, Eijsman L.
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High-dose epsilon-aminocaproic acid versus aprotinin: antifibrinolytic efficacy in first-time coronary operations.
    Eberle B, Mayer E, Hafner G, Heinermann J, Dahm M, Prellwitz W, Dick W, Oelert H.
    Ann Thorac Surg; 1998 Mar; 65(3):667-73. PubMed ID: 9527193
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K, Zimmermann T, Kampe S, Kasper SM, Weber HJ, Geissler HJ, Mehlhorn U.
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [Abstract] [Full Text] [Related]

  • 11. Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients.
    Bernet F, Carrel T, Marbet G, Skarvan K, Stulz P.
    J Card Surg; 1999 Jan; 14(2):92-7. PubMed ID: 10709819
    [Abstract] [Full Text] [Related]

  • 12. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A, Hiippala S, Vahtera E, Rasi V, Salmenperä M.
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant Group.
    Gu YJ, de Haan J, Brenken UP, de Boer WJ, Prop J, Van Oeveren W.
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):599-606. PubMed ID: 8800145
    [Abstract] [Full Text] [Related]

  • 15. Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass.
    Khalil PN, Ismail M, Kalmar P, von Knobelsdorff G, Marx G.
    Thromb Haemost; 2004 Sep; 92(3):568-74. PubMed ID: 15351853
    [Abstract] [Full Text] [Related]

  • 16. Effects of minimal-dose aprotinin on coronary artery bypass grafting.
    Hayashida N, Isomura T, Sato T, Maruyama H, Kosuga K, Aoyagi S.
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):261-9. PubMed ID: 9270645
    [Abstract] [Full Text] [Related]

  • 17. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Greilich PE, Jessen ME, Satyanarayana N, Whitten CW, Nuttall GA, Beckham JM, Wall MH, Butterworth JF.
    Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
    [Abstract] [Full Text] [Related]

  • 18. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K, Beattie WS, Dattilo KM, McCluskey SA, Ghannam M, Hamdy A, Wijeysundera DN, Fedorko L, Yau TM.
    Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
    [Abstract] [Full Text] [Related]

  • 19. [Tranexamic acid versus aprotinin for the prevention of bleeding during mitral valve surgery ].
    Ait Houssa M, Boulahya A, Wahid FA, Elbekkali Y, Amahzoune B, Selkane C, Elkirat A, Jabrani K, Ibbat D, Azendour H, Mamoun F, Arji M.
    Ann Cardiol Angeiol (Paris); 2003 Apr; 52(2):125-8. PubMed ID: 12754971
    [Abstract] [Full Text] [Related]

  • 20. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
    Penta de Peppo A, Pierri MD, Scafuri A, De Paulis R, Colantuono G, Caprara E, Tomai F, Chiariello L.
    Tex Heart Inst J; 1995 Apr; 22(3):231-6. PubMed ID: 7580360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.